Saliva Microbiome Holds Key to Lung Cancer Treatment

Groundbreaking research links oral bacteria to immunotherapy response

Apr. 11, 2026 at 2:36am

Got story updates? Submit your updates here. ›

A vibrant, neon outline of a human lung against a dark background, symbolizing the intricate connection between the oral microbiome and cancer treatment response.Groundbreaking research suggests the key to more effective lung cancer treatments may lie in the microbes living in our mouths.Chicago Today

Researchers have discovered a fascinating link between the microbes in a person's saliva and how well they respond to immunotherapy for advanced lung cancer. The study found that specific 'signatures' within the salivary microbiome could predict a patient's response to immune-checkpoint inhibitors, potentially paving the way for more personalized treatment strategies.

Why it matters

This research highlights the broader influence of the microbiome on cancer treatment, opening the door to investigating how these tiny organisms can impact the effectiveness of various therapies. It could revolutionize how we approach cancer treatment, moving us closer to truly personalized medicine.

The details

The study, led by researchers including Cavaliere, Fogolari, and Iuliani, found that patients with higher levels of the bacteria Actinomyces in their saliva showed better responses to immune-checkpoint inhibitors (ICIs) for non-small cell lung cancer (NSCLC). This is a crucial finding, as it could allow doctors to use a simple saliva sample to get a glimpse into how a patient might fare with immunotherapy, rather than relying solely on current methods.

  • The study was published in April 2026.

The players

Cavaliere

A researcher who co-led the study on the link between the salivary microbiome and lung cancer immunotherapy response.

Fogolari

A researcher who co-led the study on the link between the salivary microbiome and lung cancer immunotherapy response.

Iuliani

A researcher who co-led the study on the link between the salivary microbiome and lung cancer immunotherapy response.

Actinomyces

A type of bacteria found in the salivary microbiome that was associated with better responses to immune-checkpoint inhibitors in lung cancer patients.

Got photos? Submit your photos here. ›

What they’re saying

“This discovery isn't just about lung cancer. It highlights the broader influence of the microbiome on cancer treatment. It opens the door to investigating how these tiny organisms can impact the effectiveness of various therapies.”

— Cavaliere, Researcher

What’s next

The researchers plan to conduct further studies to validate their findings and explore the potential of using salivary microbiome analysis to guide personalized cancer treatment strategies.

The takeaway

This research could revolutionize how we approach cancer treatment, moving us closer to truly personalized medicine by leveraging the insights hidden in our own saliva. It highlights the powerful influence of the microbiome and opens up new avenues for enhancing the effectiveness of cancer therapies.